Impact of drug use policy on the appropriate use of direct acting antiviral agents for Hepatitis C in Saudi Arabia

Ahmed Saqer Alotaibi¹, Nour Shamas², Umair Uddin Ansari³, Faisal M Sanai⁴, Ali Alshahrani⁵, Ahmed Ibrahim Fathelrahman⁵, Mohammed Ali Aseeri^6
1 Clinical Pharmacist, Pharmaceutical care Department, King Abdulaziz Specialist Hospital – Taif, Saudi Arabia
² Clinical Pharmacist, Pharmaceutical Care Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia
³ Critical Care Clinical Pharmacist, Pharmacy Department, Suburban Hospital Johns Hopkins Medicine, Bethesda, Maryland, USA
⁴ Consultant Transplant Hepatologist, Gastroenterology Unit, Department of Medicine, King Abdulaziz Medical City - Jeddah, Saudi Arabia
⁵ Department of Clinical Pharmacy, College of Pharmacy, Taif University, Saudi Arabia
⁶ Clinical Pharmacist, Pharmaceutical care Department, King Abdulaziz Medical City; College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia

Correspondence Address:
Dr. Ahmed Ibrahim Fathelrahman
Department of Clinical Pharmacy, College of Pharmacy, Taif University, Taif
Saudi Arabia

Source of Support: None, Conflict of Interest: None

Check

DOI: 10.4103/jpbs.jpbs_166_21